/ CompletedNot Applicable 利培酮口崩片在健康成年受试者空腹和餐后状态下的单中心、开放、随机、单剂量、两周期、两序列、交叉生物等效性研究
[Translation] A single-center, open-label, randomized, single-dose, two-period, two-sequence, crossover bioequivalence study of risperidone orodisintegrating tablets in healthy adult subjects under fasting and fed conditions
评估受试制剂利培酮口崩片与参比制剂在健康成年受试者空腹和餐后状态下的生物等效性研究
[Translation] A study to evaluate the bioequivalence of the test product, risperidone orodisintegrating tablets, and the reference product in healthy adult subjects under fasting and fed conditions
/ CompletedNot Applicable 评估受试制剂枸橼酸坦度螺酮片与参比制剂在健康成年受试者空腹和餐后状态下的生物等效性研究
[Translation] A study to evaluate the bioequivalence of the test preparation, tandospirone citrate tablets, and the reference preparation in healthy adult subjects under fasting and fed conditions
评估受试制剂枸橼酸坦度螺酮片与参比制剂在健康成年受试者空腹和餐后状态下的生物等效性研究
[Translation] A study to evaluate the bioequivalence of the test preparation, tandospirone citrate tablets, and the reference preparation in healthy adult subjects under fasting and fed conditions
100 Clinical Results associated with Medisan Pharmaceutical Co.,Ltd.LANXI
0 Patents (Medical) associated with Medisan Pharmaceutical Co.,Ltd.LANXI
100 Deals associated with Medisan Pharmaceutical Co.,Ltd.LANXI
100 Translational Medicine associated with Medisan Pharmaceutical Co.,Ltd.LANXI